Invent Medic Sweden AB (XSAT:IMS) Stock Based Compensation: kr0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:IMS Invent Medic Sweden AB XSAT:IMS
25 GF Score
Price kr0.12
GF Value kr0.13
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Invent Medic Sweden AB Stock Based Compensation?

Invent Medic Sweden AB XSAT:IMS +2.50% 25 Stock Based Compensation is kr0.00 Mil as of Jun. 2026. GuruFocus rates XSAT:IMS with a GF Score™ of 25/100 and a GF Value™ of kr0.13 (Fairly Valued). The stock has 3 warning signs investors should review.

Invent Medic Sweden AB's Stock Based Compensation for the three months ended in Jun. 2026 was kr0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was kr0.00 Mil.


Invent Medic Sweden AB Stock Based Compensation Related Terms


Invent Medic Sweden AB Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Invent Medic Sweden AB's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invent Medic Sweden AB Stock Based Compensation Chart

Invent Medic Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Invent Medic Sweden AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSAT:IMS
25GF Score
Invent Medic Sweden AB XSAT:IMS
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Invent Medic Sweden AB Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

What does a Stock Based Compensation of kr0.00 Mil mean?
Invent Medic Sweden AB (XSAT:IMS) has a Stock Based Compensation of kr0.00 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Invent Medic Sweden AB and its competitors.
Is Invent Medic Sweden AB's Stock Based Compensation too high?
Invent Medic Sweden AB's current Stock Based Compensation is kr0.00 Mil. Overall, Invent Medic Sweden AB has a GF Score™ of 25/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Invent Medic Sweden AB's Stock Based Compensation compare to ABT and SYK?
Invent Medic Sweden AB's Stock Based Compensation of kr0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Invent Medic Sweden AB and its competitors. Invent Medic Sweden AB's current Stock Based Compensation is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invent Medic Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Invent Medic Sweden AB (XSAT:IMS) is currently considered Fairly Valued. The stock's GF Value™ is kr0.13, compared to a current price of kr0.12 — trading 5.4% below its estimated fair value. The current Stock Based Compensation is kr0.00 Mil. Invent Medic Sweden AB's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Invent Medic Sweden AB (XSAT:IMS), the current Stock Based Compensation is kr0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Invent Medic Sweden AB (XSAT:IMS) Overvalued in 2026?

Based on GuruFocus' analysis, Invent Medic Sweden AB stock appears to be undervalued. The current stock price of kr0.12 is trading 5.4% below its estimated GF Value™ of kr0.13. GuruFocus considers Invent Medic Sweden AB to be Fairly Valued.

Key valuation signals for XSAT:IMS:

  • Stock Based Compensation: kr0.00 Mil
  • GF Value™: kr0.13 vs. price of kr0.12 (5.4% below fair value)
  • GF Score™: 25/100 with 3 warning signs

No single metric tells the full story. See the XSAT:IMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Invent Medic Sweden AB Business Description

Address Nytenkargatan 4, Lund, SWE, 223 63
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.
25GF Score

Get the complete analysis for XSAT:IMS

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.12
Price
kr0.13
GF Value